GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,957,000 | -12.6% | 71,759 | 0.0% | 0.15% | -14.0% |
| Q2 2020 | $4,530,000 | -24.9% | 71,759 | -39.2% | 0.17% | -37.0% |
| Q1 2020 | $6,033,000 | -48.4% | 118,083 | -19.8% | 0.27% | -38.2% |
| Q4 2019 | $11,698,000 | +159.4% | 147,168 | +58.3% | 0.44% | +124.4% |
| Q3 2019 | $4,510,000 | +27.0% | 92,957 | +37.7% | 0.20% | +35.9% |
| Q2 2019 | $3,551,000 | -22.0% | 67,516 | -21.5% | 0.14% | -21.6% |
| Q1 2019 | $4,551,000 | +18.0% | 85,988 | -8.4% | 0.18% | +12.1% |
| Q4 2018 | $3,856,000 | -23.3% | 93,924 | -29.0% | 0.16% | -9.3% |
| Q3 2018 | $5,026,000 | +87.3% | 132,270 | +122.7% | 0.18% | +78.4% |
| Q2 2018 | $2,684,000 | -57.2% | 59,390 | -54.3% | 0.10% | -58.2% |
| Q1 2018 | $6,276,000 | +22.7% | 129,948 | 0.0% | 0.24% | +23.9% |
| Q4 2017 | $5,113,000 | +163.4% | 129,948 | +107.9% | 0.20% | +185.5% |
| Q3 2017 | $1,941,000 | -43.2% | 62,500 | -50.0% | 0.07% | -45.7% |
| Q2 2017 | $3,419,000 | -46.2% | 125,000 | -27.5% | 0.13% | -48.4% |
| Q1 2017 | $6,357,000 | +15.4% | 172,500 | -54.8% | 0.25% | +4.7% |
| Q4 2016 | $5,510,000 | +91.3% | 381,300 | +205.0% | 0.24% | +111.7% |
| Q3 2016 | $2,881,000 | +38.9% | 125,000 | 0.0% | 0.11% | +30.6% |
| Q2 2016 | $2,074,000 | – | 125,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |